These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6029531)

  • 1. 1,6-Dibromo-1,6-dideoxy-dulcitol: a new antitumoral agent.
    Kellner B; Németh L; Horváth P; Insitóris L
    Nature; 1967 Jan; 213(5074):402-3. PubMed ID: 6029531
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology of 1,6-Dibromo-1,6-dideoxy-dulcitol and its Cytostatic effect on transplantable tumours.
    Kellner B; Németh L; Sugár J; Gáti E; Pályi I; Döbrössy L
    Arzneimittelforschung; 1967 Aug; 17(8):1037-43. PubMed ID: 5244384
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaco-biochemical studies on cytotoxic polyol derivates. I. Effects of 1-6-dibromo-1-6-dideoxy-dulcitol on sensitive, resistant and refractor tumours.
    Vályi-Nagy T; Jeney A; Szabó J; Szabó I; Institoris L
    Eur J Cancer (1965); 1969 Sep; 5(4):403-14. PubMed ID: 5346869
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and pharmacologic experience with dibromodulcitol (NSC-104800). A new antitumor agent.
    Sellei C; Eckhardt S; Horváth IP; Kralovánszky J; Institóris L
    Cancer Chemother Rep; 1969 Dec; 53(6):377-84. PubMed ID: 4915082
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative data on the action mechanism of 1,6-dibromo-1,6-dideoxy-D-mannitol and 1,4-dimethanesulfonyloxy-n-butane.
    Institóris L; Eckhardt S; Horváth IP; Sellei C
    Arzneimittelforschung; 1966 Jan; 16(1):45-50. PubMed ID: 5233532
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of dibromodulcitol (NSC 104800) on intravenously induced cytemia of rats.
    Németh L
    Neoplasma; 1971; 18(5):533-7. PubMed ID: 5119525
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of the chemical structure on the biological endency of cytostatic compounds related to dibromomannitol. I. Structure-activity correlations.
    Institóris L; Horváth IP; Csányi E
    Arzneimittelforschung; 1967 Feb; 17(2):145-9. PubMed ID: 5631481
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologic and antitumor effects of 1,2:5,6-dianhydrogalactitol (NSC-132313).
    Németh L; Institóris L; Somfai S; Gál F; Pályi I; Sugár J; Csuka O; Szentirmay Z; Kellner B
    Cancer Chemother Rep; 1972 Oct; 56(5):593-602. PubMed ID: 4652589
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacology of polyriboinosinic: polyribocytidylic acid, a new antiviral and antitumor agent.
    Adamson RH; Fabro S; Homan ER; O'Gara RW; Zendzian RP
    Antimicrob Agents Chemother (Bethesda); 1969; 9():148-52. PubMed ID: 4990370
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental methodology for the selection of potential anticancer agents].
    Pérez Mínguez F; Llombart Bosch A
    Rev Esp Oncol; 1982; 29(4):593-602. PubMed ID: 6927364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the treatment of malignant tumor with fibroblast-inhibiting agents].
    Hiraki K; Kimura I; Kageyama H; Kawanishi K; Moritani Y
    Gan No Rinsho; 1966 Aug; 12(8):499-511. PubMed ID: 6011017
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antitumoral and toxicological properties of extracts of bark and various wood components of Pau d'arco (Tabebuia avellanedae)].
    de Santana CF; de Lima Og; d' Albuquerque IL; Lacerda AL; Martins DG
    Rev Inst Antibiot (Recife); 1968 Dec; 8(1):89-94. PubMed ID: 5761014
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antitumor activity of prospidin].
    Sorkina IuA; Chernov VA; Grushina AA; Khramchenkova SP
    Vopr Onkol; 1970; 16(7):83-6. PubMed ID: 5274101
    [No Abstract]   [Full Text] [Related]  

  • 14. [Methodical aspects in studies on the carcinogenesis and chemotherapy of tumors].
    Schmähl D
    Planta Med; 1968; ():3-12. PubMed ID: 4976078
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental and clinical study of antileukemic activity of N, N'-diethylene-N"-cyclohexyltriamidothiophosphate (hexaphosphamide)].
    Khomchenovskiĭ EI; Nevskaia TP; Cherntsova TA; Susoeva VM
    Probl Gematol Pereliv Krovi; 1968 Oct; 13(10):49-56. PubMed ID: 5259518
    [No Abstract]   [Full Text] [Related]  

  • 16. [On some biological effects of the cytostatic agent verrucarin A].
    Rüsch ME; Stähelin H
    Arzneimittelforschung; 1965 Aug; 15(8):893-7. PubMed ID: 4955716
    [No Abstract]   [Full Text] [Related]  

  • 17. 1,6-Di-O-methanesulphonyl-2,3-4,5-dianhydro-L-iditol, a new potential antitumour agent. Biological investigations.
    Csányi E; Halász M
    Arzneimittelforschung; 1973 Jul; 23(7):961-7. PubMed ID: 4356189
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of zymosan on the toxicity and activity of various antitumor preparations].
    Veksler IG
    Vopr Onkol; 1966; 12(8):80-6. PubMed ID: 4972211
    [No Abstract]   [Full Text] [Related]  

  • 19. Antitumoral effects of lipid A: preclinical and clinical studies.
    Pance A; Reisser D; Jeannin JF
    J Investig Med; 2002 May; 50(3):173-8. PubMed ID: 12033281
    [No Abstract]   [Full Text] [Related]  

  • 20. [Segidrin: a new-type antineoplastic agent].
    Filov VA
    Vopr Onkol; 1994; 40(1-3):3-14. PubMed ID: 7701790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.